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ABBREVIATIONS
AIDS acquired immunodeficiency syndrome
CBO community-based organization
CDC U.S. Department of Health and Human Services—
Centers for Disease Control and Prevention
CI contact investigator
CM case manager 
CXR chest x-ray
DCI disease control investigator 
DOH Department of Health 
HIV human immunodeficiency virus
LTBI latent tuberculosis infection
MD medical doctor 
PHN public health nurse
TB tuberculosis 
TST tuberculin skin test
VCT voluntary counseling and testing
MDR-TB multidrug-resistant tuberculosis
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INTRODUCTION
Tuberculosis (TB) contact investigations are conducted to find persons who have
been exposed to patients with active tuberculosis and to evaluate and treat those
persons for TB infection and active TB. Someone with latent TB infection (LTBI) and
HIV is up to 800 times more likely to develop active TB disease during his or her
lifetime than someone without HIV.1 HIV is the leading factor for activation of LTBI
to active disease. Until recently, the efforts to control TB among HIV-infected
people have focused mainly on active TB patients.
While voluntary HIV testing for TB contacts has been recommended since 1996, a
recent CDC study2 has shown that most of the country had limited documentation
of HIV status of TB contacts. As a result of not knowing their HIV status, some
contacts might experience delayed diagnoses of LTBI or active TB, resulting in
missed opportunities for TB treatment and the prevention of TB transmission. This
Guide aims to strengthen the Contact Investigator’s skills in engaging clients in
discussion about HIV counseling, testing, and referral. HIV counseling and testing
must be seen as the standard of care for TB assessment and treatment of
tuberculosis. 
The guide is divided into three major parts. The first part is designed to provide the
Contact Investigator with the essential HIV/AIDS information he or she will need
when engaging in a family-friendly discussion to encourage TB contacts to agree
to HIV counseling and testing. The second is designed to give TB program
managers guidelines for implementing a program tailored to their jurisdiction. The
last part details a training course that will impart the skills, attitudes, and
knowledge one will need to include HIV in tuberculosis contact investigations. This
course can be conducted for a half or full day.
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1 Centers for Disease Control and Prevention. TB and HIV Coinfection: What Can HIV/AIDS Service Organizations
Do to Help?
2 Centers for Disease Control and Prevention. Missed opportunities for the prevention of tuberculosis among
persons with HIV infection–Selected locations, United States, 1996-1997. MMWR 2000; 49 (No. 30; 685).
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CONTACT INVESTIGATORS’ RESOURCE GUIDE 
The purpose of this part of the guide is to provide Contact Investigators (CIs) with the necessary
information to assist them in engaging TB contacts in discussions about voluntary counseling and
testing (VCT) for HIV. The field staff that conduct contact investigations must be equipped with the
appropriate knowledge, skills, and sensitivity to encourage TB contacts to volunteer for HIV
counseling and testing. It is the role of the CI to educate contacts of persons with active TB about
the risk of TB and the link with HIV infection. In addition to routine information about TB, the CI
must explain the greater risk of TB if the person is HIV positive and has LTBI. 
After reading this guide, a CI will be empowered with an HIV/AIDS education message that is
family friendly and can be used in a variety of contact investigation situations. A confident and
skilled CI can develop better communications with contacts and establish a trusting relationship
that will lead to referrals for HIV VCT.
There are many barriers that prevent contacts from accepting HIV VCT. This guide identifies and
examines some of those barriers. Exploring these barriers better prepares the CI for the task of
encouraging contacts to accept HIV VCT. The CI will need to recognize these barriers and be able
to offer valid reasons why the contact should find it important and necessary to accept HIV VCT.
Ultimately, the CI should be able to communicate that HIV VCT is a standard component of care
for persons with LTBI.
INTRODUCTION
Contact investigations are conducted to find persons who have been exposed to someone with
active TB and to evaluate and treat those contacts for LTBI and active disease, if detected. Persons
in close contact with patients with active TB are at high risk for LTBI. The risk for progression of
latent LTBI to TB disease is increased greatly if the person is infected with HIV. Therefore, it is very
important for Contact Investigators to engage close contacts in discussion regarding the
importance of knowing their HIV status through HIV counseling and testing.
In 2000, the CDC published a study on the missed opportunities for the prevention of TB
among persons with HIV infection.3 The study examined the clinical records of TB programs to
determine whether these programs used recommended practices to manage HIV-positive
persons exposed to TB.
The results of this study suggested that TB programs need to review their contact investigation
policies, procedures, and outcomes to reduce missed opportunities for preventing active TB among
HIV-infected close contacts. It was reported that few close contacts were assessed for HIV and
one-fourth of those known to be HIV-infected did not receive complete screening for TB. Of the
HIV-infected contacts eligible for LTBI treatment, only one-third started LTBI treatment, and only
one-sixth completed it.
3 Centers for Disease Control and Prevention. Missed opportunities for the prevention of tuberculosis among persons with HIV
infection–Selected locations, United States, 1996-1997. MMWR 2000; 49 (No. 30; 685).
The findings in this study indicate a need for better integration of HIV assessment into TB contact
investigation procedures and improved coordination between local TB and HIV programs to
facilitate voluntary counseling, testing, and follow-up for HIV-infected close contacts. Both
healthcare providers and HIV-infected persons need to be aware of optimal management of close
contacts and of the benefits of prompt and well-supervised LTBI treatment to prevent active TB.
Definition of Terms
Endemic
A disease that is prevalent in a certain group of people or in people living in a particular location.
Incubation Period
The time between when a person gets HIV (initial infection) to the time that AIDS develops. AIDS
is considered a very advanced stage of HIV infection. Specific criteria are used to diagnose AIDS. 
Perinatal Transmission 
The transmission of HIV infection from an HIV-infected mother to her infant during pregnancy,
labor and delivery, or breastfeeding.
T Cell
A key infection fighter in the human body’s immune system. The term generally refers to a specific
kind of T Cell called a CD4 positive T Cell. Sometimes these cells are also called CD4 Cells.
Window Period
The time between when a person is infected with HIV and when there are enough antibodies to
be detected using current HIV testing methods. Most people infected with HIV will develop
enough antibodies to be detected by one month. Virtually all people infected will develop
antibodies by three months.
TB AND HIV/AIDS 
In a needs assessment conducted for Contact Investigators in a local public health department,
Contact Investigators were interviewed and observed in the field. 
The observation revealed that many TB Contact Investigators were very confident in their ability to
communicate with people about TB disease and LTBI. However, they did not have the same
comfort level when addressing HIV/AIDS issues. Most felt they did not have enough detailed
information on HIV/AIDS to engage in a discussion on this subject and to refer the person for HIV
testing. They feared being asked questions they could not answer. They were also concerned that
discussion regarding HIV may need to include sensitive topics such as sexuality or substance use,
issues that are difficult to discuss in a setting with limited privacy such as the home. 
The following is basic information that a Contact Investigator might need when discussing
voluntary HIV counseling and testing. 
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The TB-HIV Link 
HIV weakens the immune system, and TB thrives in a person with a weakened immune system.
Thus, HIV speeds development of TB:
• Someone who is HIV infected and infected with TB (i.e., with LTBI) is up to 800 times more
likely to become sick with TB than someone who is HIV negative and infected with TB. 
• HIV is the most powerful known risk factor for progression of LTBI to active TB disease 
• TB is the leading cause of death among people who are HIV-infected in many parts of the
world. In Africa, one-third of all AIDS-related deaths are due to TB.
Risk Factors for LTBI and TB Disease4
High risk for TB infection (LTBI)
• Contact with someone with TB
• Born in or visited countries where 
TB is common
• Use drugs or excessive alcohol 
• Live or work in nursing homes, shelters,
or prisons
• Exposed to TB on the job 
• HIV infected
• Conditions such as diabetes, old TB, 
kidney problems, or cancer
Multidrug-Resistant TB (MDR-TB)
MDR-TB is becoming an increasing problem in the world. It is now thought that up to four
percent of the world’s TB cases are MDR-TB. Because MDR-TB cannot be treated with standard TB
therapies, treatment requires up to two years. During that time, the patient is infectious longer
than patients with non-resistant TB. MDR-TB is more often fatal than non-resistant TB.
HIV-infected individuals who are exposed to MDR-TB, if infected with such organisms, are at
greater risk of progressing to MDR-TB disease. Therefore, it is very important to rigorously screen
and evaluate contacts of patients with MDR-TB for possible HIV co-infection.
While the number of cases of MDR-TB has remained stable in the United States over the past few
years, cases of MDR-TB have been reported in 43 states and the District of Columbia.
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High risk for TB disease once infected
• People with HIV infection
• People with other medical conditions that
appear to increase the risk for TB
• People recently infected within the past two
years
• People with chest x-ray findings suggestive of
previous TB disease
• People who inject illicit drugs 
4 U.S. Department of Health and Human Services Public Health Services, Centers for Disease Control, Self-Study Modules on
Tuberculosis, March 1995, Modules 1& 2."
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UNDERSTANDING HIV/AIDS
The Basics
What is HIV? What is AIDS?
HIV stands for Human Immunodeficiency AIDS stands for Acquired Immunodeficiency
Virus. HIV causes the gradual deterioration Syndrome. The term “AIDS” applies to the
of the body’s immune system by killing most advanced stages of HIV infection. The
T Cells. The body then becomes susceptible official criteria for the definition of AIDS 
to various other diseases. These diseases are were developed by the CDC. The definition
called “opportunistic Infections”, because includes all people with T Cell counts less
they do not normally infect healthy people. than 200. In addition, the definition of AIDS
includes 26 specific clinical conditions, most 
of which are opportunistic infections.5
A normal person starts with 1,000–1,200 T Cells in every cubic millimeter of blood. HIV attacks
the body by infecting and destroying those T Cells, thereby reducing the body’s ability to defend
itself against infections. Even when there are no symptoms of HIV infection, the virus is actively
multiplying and infecting and killing T Cells. As the immune system weakens, a variety of things
begin to happen to the body. Sometimes, the first signs of HIV infection are swollen lymph nodes.
Other symptoms that can be experienced before the onset of AIDS include:
• Lack of energy
• Weight loss
• Frequent fevers and sweats
• Persistent or frequent yeast infections (oral or vaginal)
• Persistent skin rashes or flaky skin
• Pelvic Inflammatory Disease (PID) in women, which does not respond to treatment
• Short-term memory loss
When a person progresses to AIDS, the immune system is so weakened that the body cannot fight
off many kinds of bacteria, viruses, fungi, parasites, and other microbes. In addition, people living
with AIDS are more susceptible to some kinds of cancers, such as Kaposi’s sarcoma (KS) or
lymphomas. These cancers are difficult to treat in people living with AIDS.
5 Material in this section is drawn in part from National Institute of Allergy and Infectious Diseases, “HIV Infection and AIDS: An
Overview” (October 2003). This can be accessed on the Internet at the following URL. www.niaid.nih.gov/factsheets/hivinf.htm
The Two Types of HIV
1. HIV-1 is most commonly found worldwide.
2. HIV-2 is found mostly in West Africa. Many African immigrants in the United States are from
West Africa.
Comparing HIV-1 and HIV- 2 
HIV-1 vs. HIV-2
• Predominant virus found world wide 
• Rate of perinatal transmission is 14–35%
(without treatment)
• 3 times more infectious than HIV-2
• Rate of T Cell loss is 105 per year
• Incubation period is shorter than HIV-2
If a person is from a country where HIV-2 is prevalent, that person should be tested for HIV-1 and
HIV-2. The CDC reports that the following persons are at risk for HIV-2 infection.
• Persons from a country where HIV-2 is endemic
• Sex partners of a person from a country where HIV-2 is endemic
• Persons who received a blood transfusion or a nonsterile injection in a country where HIV-2 is
endemic
• Persons who shared needles with a person from a country where HIV-2 is endemic or with a
person known to be infected with HIV-2
• Children of women who have risk factors for HIV-2 infection or are known to be infected with
HIV-2
• Persons with an illness that suggests HIV infection but whose HIV-1 test result is not positive
It is important to note that TB is endemic in the same countries in which HIV-2 is endemic. It is
therefore important for the CI to have knowledge about HIV-2 when dealing with persons from
these countries.6
HIV-2 endemic areas include: Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana,
Guinea/Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Sao Tome, Senegal, Sierra
Leone, Togo, and other African countries such as Angola and Mozambique.
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• Found mostly in West Africa, not a
worldwide pandemic
• Risk of perinatal transmission is 0–4%
(without treatment)
• Less infectious (not as easily transmitted)
as HIV-1
• Rate of T Cell loss is 1% per year
(slow progression)
• Incubation period is longer than HIV-1 
6 For- more information about HIV-2, see CDC-NCHSTP—Division of HIV/AIDS Prevention—Fact Sheet—Human Immunodeficiency
Virus Type 2. This can be accessed on the Internet at the following URL. www.cdc.gov/hiv/pubs/facts/hiv2.htm.
Where HIV Can Be Found in the Body
HIV is most commonly found in human body fluids. People with HIV infection can spread HIV to
others through the following body fluids:
• Blood
• Semen
• Fluids from a women’s vagina and/or cervix (wetness in a woman’s vagina)
• Breast milk






How HIV Is Transmitted
There are many misperceptions about how HIV is spread from person to person.7 In order for any
virus to spread, certain steps must happen:
1. Someone or something must carry (or have) the virus. This is the source of the infection.
2. The virus needs a way to exit (leave) the body. With HIV, infected body fluids can exit and be
passed to others in these ways:
• During sex (anal, oral, or vaginal intercourse)
• Sharing injection drug “works”
• From mother to baby in the womb, during birth, or during breast feeding
• In accidental needle sticks or splashes, where infected blood or body fluids may infect
healthcare workers. 
• Through infected blood or body parts that are donated to others (very low risk).
3. The virus needs a way to enter another person’s body. Body fluids from a person infected with
HIV can enter another’s body in the ways listed above.
4. A virus needs someone able to get infected, a susceptible host. In the case of HIV, almost every
human is susceptible. A person only becomes infected if he or she does something to put him
or herself at risk of coming into contact with HIV infected body fluids.
10 CHARLES P. FELTON NATIONAL TUBERCULOSIS CENTER AT HARLEM HOSPITAL
7 TheBody.com is an important Internet resource for information about HIV/AIDS. In addition to posting up-to-date information, it has
an “Ask The Experts” section to answer individual questions. TheBody.com has compiled a valuable document called
“Misperceptions About HIV and Its Transmission.” It can be accessed on the Internet at the following URL.
www.thebody.com/cdc/factv.html.
How HIV Is Transmitted Through Sex
If the person infected with HIV has unprotected sex with another person, the HIV-infected semen
or vaginal fluid can enter the other person through their rectum, vagina, penis, or mouth. So, the
following sexual activities can transfer HIV from one person to another:
• Anal intercourse (penis to rectum)
• Vaginal Intercourse (penis to vagina)
• Oral Sex (mouth to penis or mouth to vagina)
• Blood in semen or vaginal fluids, directly on broken skin or mucus membranes
• Sharing of sex toys
How HIV Is Transmitted Through Sharing Needles or Drug “Works”
When a person infected with HIV shoots up and then shares the “works” with others, infected
blood gets in the “works” and will be directly injected into someone else. The following items are
part of the “works”: 
• A needle
• A syringe (barrel and plunger)
• A cooker (container used to dissolve drugs from solid to liquid; may be a spoon or bottle top)
• A cotton/filter (used to strain the drug)
• A water glass (used to rinse the syringe and/or dilute the drugs).
The HIV Test 
An HIV test administered by a physician, clinic, or anonymous testing site generally consists of two
parts. Both parts of the test check for the presence of HIV antibodies that are made by the
immune system after a person gets infected with HIV. Most people infected with HIV will develop
enough antibodies to be detected by one month. Virtually all people infected will develop
antibodies by three months. If no HIV antibodies are found, the second test is not performed.
If HIV antibodies are found in the first part of the test, an additional test is performed to confirm
their presence. The most common confirming test is called the Western Blot test. It detects specific
antibodies that are developed against HIV. 
There are currently several rapid tests for HIV. These tests can provide preliminary results in as little
as 15–20 minutes. A positive test result from a rapid test must be confirmed by an additional test,
such as the Western Blot.
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How HIV Test Result Are Reported
• Negative. A negative result means no antibodies were detected. Infection cannot be excluded
without follow-up testing, however, if client has a recent history of possible exposure. 
• Positive. A positive result means that antibodies were detected, and a Western Blot or other
test was then done to confirm the presence of HIV. This means the person is infected and can
transmit HIV to someone else.
• Indeterminate. Clients with an indeterminate Western Blot result should be retested for HIV
infection one month later. If a person with an indeterminate Western Blot test is from an area
where HIV-2 is found, an HIV-2 test may be performed. Persons with continued indeterminate
Western blot results after one month are unlikely to be infected and should be treated as
though they are not infected unless recent exposure has taken place.
The Difference Between Anonymous and Confidential Testing
Anonymous Testing 
• The person’s identity is unknown. No name is given at the antibody-testing site. A code number
is given to the person being tested. This code number is used instead of a name on the
Informed Consent to perform an HIV Test.
• Anyone who is tested anonymously for HIV at an anonymous test site has the option to convert
a positive or indeterminate result to a confidential result. They may choose to have the result
forwarded to their medical care provider. Anonymous testing sites do not provide medical care,
but they do provide counseling.
Confidential Testing 
• The person’s name is known, but it can be shared only with those who need to know the result
of the HIV antibody test. A list of those who may be able to have information about a person’s
HIV antibody test should be included in the Informed Consent to perform an HIV test.
• The person who is being tested must sign the consent with his or her name. The result of the
HIV antibody test is entered into the medical record. To get a confidential HIV test, an individual
should go to his or her doctor or clinic and ask to be tested for HIV. This is the preferred
standard of HIV testing because it is easier to follow up with the patient.
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INTRODUCTION TO VALUES CLARIFICATION
The goal of this section is to provide the CI with the knowledge and skills for effective
communication when addressing the subject of HIV/AIDS counseling and testing. The previous
section of this booklet presented scientific information the CI will need in order to effectively
answer questions and engage in knowledgeable dialogue about HIV/AIDS. This section offers a
strategy for engaging in sensitive dialogue for HIV/AIDS testing and counseling. Most importantly,
the CI must make certain that the contact understands that VCT is the standard of care for TB
assessment of someone who has been exposed to active TB.
A script is provided that reviews key facts about TB and HIV and reinforces the need for VCT. The
script included in this booklet as an appendix suggests the basic information needed to engage in
such dialog. 
The effectiveness of the discussion will depend on the CI’s comfort level with the subject. The
practical application of this training involves a review of the script and various role-playing
scenarios the CI may encounter in the field. The following section is intended for the CIs to explore
their own feelings about their personal values.
Personal Values Can Affect Communications 
Effective communication with TB close contacts on the subject of HIV/AIDS issues requires
sensitivity and respect for others who may have different ideas and values. The CI is required to
engage in personal and sometimes intimate discussions with TB close contacts. The CI must first
be aware of his or her values and feelings around HIV/AIDS issues before any attempt can be
made to engage in a discussion with TB close contacts who may need to volunteer for HIV
counseling and testing. 
Everyone has values—strong beliefs that may influence behavior. Values can be formed by the
larger community or within the individual. A good place to start looking at one’s own values is to
ask oneself, “What are the elements in my life that are truly very important to me?” The answer
to that question is an example of that person’s values.
Below are a few points that may trigger thinking about values.
Values
• Are strongly held beliefs that tend not to change
• May vary from culture to culture, group to group, etc.
• Are things that a person might fight over or die for
• May be so much a part of the person that he or she may take them for granted
• Are long-standing assumptions that do not change easily
• Can be something that all the information in the world may not change
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It is important to note that while values are strong beliefs, they can change because of different
influences, events, people, and experiences. For example, the events of September 11, 2001,
could change how one might value one’s life. The death of a loved one from smoking may
change one’s values about smoking. Attitudes about seatbelts, gun control, and high blood
pressure are just a few values that could be subject to change in one’s life.
Contact Investigators can be more effective in providing HIV/AIDS information if they are aware of
their own values, and if they understand that values will vary from client to client. Most important,
the CI must be willing to respect people who have values different from their own.
Effective Contact Investigators are aware of their personal values and develop strategies that allow
them to work with situations when their values differ from those of a person whom they are
educating, or when their personal values are in conflict with the HIV/AIDS information that must
be provided.8
A Values Clarification exercise and a questionnaire are included in the training part of this booklet.
(p. 27)
8 Community HIV/AIDS Educator Curriculum, Trainers Manual, Office of the Medical Director, AIDS Institute, New York State
Department of Health. 
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IMPLEMENTATION GUIDE 
This section is for program managers. It is intended to provide guidelines for designing a program
that will integrate efforts to address HIV/AIDS issues in conducting TB contact investigations.
Flexible communication and coordination are the keys to establishing a program that may link TB
and HIV testing services and other institutions. The following is a simple outline to assist in
planning a program. 
TB/HIV PROGRAM ESSENTIALS 
A few key questions need to be asked before program implementation. The first step is to assess
the program area’s regulations and protocols for networking TB services and VCT for HIV. The
program manager should delineate in detail how the network is designed and currently
functioning. This delineation should include the network’s delivery of services, referral links,
documentation, reporting, and local regulations. This will enable the program manager to make
decisions about how to implement the program and conduct training.
Determine Patient Flow
The following are possible paths for the flow of patient information, testing, and services:
If the Department of Health If the Department of Health 
is the only agency is working with outside agencies
DOH Contact Investigator DOH Contact Investigator
Contact
DOH HIV VCT




Conduct a Needs Assessment 
A needs assessment is always helpful in deciding how to address a new issue in any program.
Once information has been gathered and analyzed, it will become the foundation on which to
continue program planning. The most common approaches to needs assessment are listed below.
Each method has certain advantages and disadvantages.
1. A needs assessment questionnaire can be helpful, as it can supply documented data as to the
various issues that will need to be addressed in the training. 
• List specific questions or concerns CIs may have about the topic.
• Ask CIs to do a self assessment or to fill out a questionnaire.
• Gather and sort the responses to incorporate in planning the program and the training.
2. Here is a suggested observation and interview approach. 
• Interview CIs and observe their work in the field.
• Conduct focus groups with CIs. 
• Interview a person who would do VCT for TB contacts referred by a CI and observe the
interaction with clients (if the client’s permission can be obtained).
• Observe the clinic and/or field setting where VCT would take place (permission is needed).
• Test CIs’ knowledge.
Below is an example of findings from a needs assessment conducted in a local health department: 
In one municipal health department, a needs assessment revealed that CIs were confident
about their general knowledge of TB, could establish trust, and could inform their contacts
about all aspects of the TB testing and treatment process. However, they did not feel
confident about engaging TB contacts in discussions about HIV voluntary counseling and
testing. Most CIs admitted having sufficient knowledge of TB and the HIV connection, but
they did not feel confident about engaging contacts in any type of discussion around
voluntary counseling and testing of HIV.
Most CIs felt that they did have some knowledge of HIV, but not enough to educate close
contacts in a family-friendly manner. In addition, without additional training, they were not
confident that they could bring the intimate subject up in a manner that would not offend or
be misinterpreted by the close contact. 
The health department decided to arrange for VCT to be offered at the chest clinic, the same
place where clients are diagnosed and treated for TB disease and LTBI. A formal letter from
the Director of the TB control program was sent to all supervisors and contact investigators.9
The letter stated the need to inform close contacts that HIV testing is part of the standard
evaluation of a TB contact.
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9 See the Sample Letter From the Department of Health found on page 35 of this booklet.
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Set Goals 
By setting goals, everyone will have a clear vision of what the program is intended to accomplish
and what the expected outcomes are. It is a good idea to involve staff from all groups who will be
involved in this new coordinated effort: CI staff, VCT staff, and chest clinic staff. Here are a few
suggested goals. 
• To increase HIV voluntary counseling and testing of close contacts to infectious TB patients
• To promptly identify active TB in HIV-infected close contacts
• To prevent active TB through treatment of LTBI in HIV-infected contacts once active TB has been
excluded
• To prevent AIDS in HIV-infected persons through referrals to HIV care
• To reinforce HIV assessment skills
• To reinforce knowledge and understanding of relationship between TB and HIV
Identify priority population and decide who should be offered HIV counseling, testing,
and referral.
For example, one health department decided to offer HIV VCT to:
• All persons 13 years of age and older who are close contacts to a pulmonary (sputum
smear +, cavitary CXR, or culture positive) or laryngeal TB case and who do not know their
HIV status, regardless of TST result 
• Close contacts younger than 13 years, whose biological mother is HIV infected. 
• All persons 13 years of age and older who are contacts to an active TB case and/ or have
at least one risk factor for HIV infection.
Create policy for how HIV results will be documented.
Below is an example of one health department policy on the documentation of HIV status:
• HIV status must be recorded on all patients placed on treatment for LTBI. 
• Patients who self-report having tested for HIV positive or negative without documentation must
be further probed to ensure the authenticity of the information. If this cannot be determined,
the status should be documented as unknown.
• To assist a patient in obtaining the documentation of HIV test results, the information can be
requested from the provider who performed the test. For this, the patient must sign the State-
approved consent form for the release of HIV information.
The HIV status should be documented as negative if the patient has had a documented negative
HIV antibody test within the year prior to diagnostic evaluation for tuberculosis. It is not acceptable
if the patient reports being HIV negative, but there is no documentation. The patient should be
offered the opportunity to be tested for HIV. 
HIV status should be documented as positive if:
• The patient is tested for HIV and the laboratory result is interpreted as positive according to
published criteria, or
• The patient has documented medical history of a previous positive HIV test or a previous
diagnosis of HIV infection or AIDS, or 
• The patient gives history (e.g., an oral statement) of a previous positive HIV test or can
document treatment for HIV infection. In this case, the patient should be asked to provide a
record of a prior test or be retested.
There are other possibilities for HIV status that must be documented:
• HIV status is indeterminate if HIV test results are recorded as such.
• HIV status is refused if the patient was offered an HIV test but declined to be tested.
• HIV status is not offered if patient was not offered the test at the time of the TB diagnostic
work up. If patient had a documented negative HIV test more than a year ago and was not
retested, consider the status as not offered.
• HIV status is test done, results unknown if patient has been tested and the tuberculosis
program does not know the results.
• HIV status is unknown if none of the previous categories apply.
Decide when appointments should be scheduled for VCT.
1. If contact is TST positive, a VCT appointment should be given on the same day as CXR/MD
appointment.
2. If contact is TST negative, provide VCT appointment within 24 hours. If there is not enough
time to set up an appointment in advance, give a Clinic Visit Card to the contact to be used as
a pass to the Chest Center for immediate VCT. In a group setting where more than one TST-
negative close contact is present, if one of them agrees to come to clinic for counseling, give
Clinic Visit Cards to all contacts who are present even if they decline.
Set Objectives
Setting objectives gives the program director and trainer a comprehensive plan of action and idea
of the anticipated outcome. It will also be helpful for future participant and training evaluations.
Below are a few suggested program objectives:
1. To offer HIV VCT services to all close contacts of infectious TB patients.
2. To screen all HIV-positive close contacts for active TB disease, and to provide referral for HIV care
and supportive services.
3. To offer LTBI treatment to HIV-positive close contacts who do not have active TB disease.
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Decide how and when communications between CI, VCT, and Health Dept Clinic staff
should be conducted. 
Effective communication is the key to successfully linking the CI, VCT, and chest clinic. Staff will
need to maintain frequent communication to ensure that contacts are identified, that they are
evaluated for TB and HIV, and that appropriate follow-up is conducted. 
For example one health department decided that they needed detailed protocols governing the
following issues in situations where follow-up was needed. 
• Appropriate documentation of all activity 
• System for referrals
• Timeframes for administrative communication
The health department also decided to use a Clinic Visit Card for VCT of a distinct design, easily
recognizable by all clinic staff, especially the receptionists in the chest clinic. This card indicates that
the person wants to see an HIV counselor on the same day as they receive their chest x-ray and
medical evaluation for LTBI. Persons carrying the card see an HIV counselor without delay.
Sample Clinic Visit Card for VCT
Patient Name:____________________________________________________________________
Case number______ DOB: ____ /____ /____   Home phone #____________________________
Home address: ___________________________________________________________________
________________________________________________________________________________
City __________________________________________________State______  Zip____________
TST date ____ /____ /____   TST reading date____ /____ /____   TST results mm____________ 
Accepted appointment for VCT counseling   _______yes   _______no
CI code ______________________________________ Date card was issued ____ /____ /____
Date chest clinic visit__/___/____ Counselor_______________________________________
Decline testing  Yes  _______ No _______
Referral Procedure
Decide what to do if a contact is “not sure” or says “definitely no” about accepting HIV
VCT.
1. Document that the contact refuses HIV VCT and the reason for refusal if one is given. 
2. Discuss the case with a supervisor and make additional effort for HIV VCT on the day of the TST
reading. 
If contact is TST positive and
• Accepts HIV VCT: Make an immediate appointment for a medical evaluation. 
• Declines HIV VCT: Make an appointment for a medical evaluation at Chest Clinic and obtain
physician’s assistance to clarify the patient’s need for VCT. Continue to offer VCT again
during treatment for LTBI or active TB disease.
If contact is TST negative and
• Accepts HIV VCT: Make appointment within 24 hours.
• Declines HIV VCT: Try again on the post-window TST date, if applicable.
If a contact says he/she has been tested for HIV previously
• Find out if the HIV test was documented. 
• Get the date and location the test was administered.
• Record the results and follow-up accordingly.
Decide what documentation is needed between field and office staff.
CI should report the TST and VCT results for each contact to the supervisor using a log that
includes:
• Patient’s name or case number
• Patient’s address
• Testing Date
• Reading date and time
• Reading location (detail the address for follow-up)
Document the following;
• Acceptance of HIV VCT appointment (yes/no) 
• Clinic Visit Card given to contact 
• CXR and medical evaluation appointment date and clinic
• Include comments or specific request 
• Any concerns mentioned by the contact 
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TRAINING GUIDE 
INTRODUCTION
This part of the booklet is designed as a guide to furnish the trainer with the necessary tools to
prepare contact investigators to engage in discussions with contacts around the issues of HIV and
VCT. Specific qualifications of the trainers are essential for this unit; different sessions require
trainers with different backgrounds. Trainers should be considered based on their HIV/AIDS
background and their understanding of local health services. 
The time allotted for each lesson may vary from 30 to 90 minutes. The following materials should
be available for the learning process. 
Materials and equipment
You will need one of the following ways to share information with the group:
• Laptop with PowerPoint slides and multimedia projector
• Transparencies and overhead projector
• Newsprint and markers and easel or masking tape
TRAINING SCHEDULE
Time Content Methodology 
9:00 Introduction of participants, schedule
9:15 Pre-test (p. 23) Ten minutes 
9:30 Lesson One Lecture & Discussion 
TB/HIV Background (p. 24) Appendix 1-MMWR art.
Risk factors, role of VCT in CI, MDR-TB Booklet p. 4–7
10:00 Lesson Two (p. 25) Lecture & Discussion
What is HIV? Booklet p. 8–11
Definition of HIV, AIDS, 2 types of HIV, Appendix 2 
HIV transmission
11:00 Break 15 minutes
11:15 Lesson Three Lecture & Discussion 
HIV Testing (p. 26) Booklet p. 11–12 
Define window period, explain test results, 
types of testing 
11:45 LUNCH 
1:15 Lesson Four Lecture & Discussion
Values Clarification (p. 27) Values Clarification 
Explore what influences values, Questionnaire p. 37
change in values, adapting 
to change in one’s values 
1:45 Lesson Five Lecture & Discussion
TB-HIV Project Implementation (p. 29) Local program area will 
Program information and data provide the materials 
reporting system
2:15 Break 15 Minutes
2:30 Lesson Six Lecture & Discussion 
Barriers in the field (p. 30) Newsprint easel, paper and 
Explore barriers and brainstorm solutions marker 
3:00 Lesson Seven Role Plays & Feedback
Simulation exercise in small groups Role-Plays p. 40
4:00 Post-test (p. 23) Ten minutes 
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ADDRESSING HIV/AIDS ISSUES IN TB CONTACT INVESTIGATION
Pre- and Post-Test
1. What is HIV?
________________________________________________________________________________________
2. What is AIDS?
________________________________________________________________________________________
3. What is the Incubation Period?
________________________________________________________________________________________
4. What is the Window Period?
________________________________________________________________________________________









6. HIV infects the white blood cells. T or F
7. CIs should offer HIV counseling and testing referral to all close contacts of infectious TB
patients. T or F
8. Describe two ways an HIV-infected person can pass the infection to another person.
________________________________________________________________________________________
________________________________________________________________________________________
9. CI should never discuss HIV information when there are several people in one apartment. Tor F





11. If we do not offer HIV counseling and testing to close contacts of infectious TB patients, we
will miss opportunities to prevent TB disease. T or F
12. The window period for HIV to be detected in the body is two to three weeks. T or F 
13 HIV confidentiality means no HIV information can be given out without an 




By the end of the session, participants will be able to:
1. Explain how the risk of TB disease is increased if close contact is HIV positive
2. State why it is important to engage close contact in discussions regarding VCT
Lecture/Discussion
• Risk factors for LTBI and TB disease
• The role of VCT in contact investigation
• Significance of MDR-TB
Trainer’s Notes
Trainer should be familiar with local health services. He or she will need to prepare lectures notes
ahead of time by using materials from Section II of the Resource Guide. Explain to participants that
the MMWR article “Missed opportunities for preventing active TB among HIV positive close
contacts” is a background source for this training.
Preparation
Include Appendix 1 from this booklet.
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LESSON TWO
WHAT IS HIV? 
Objectives
By the end of the session, the participant will be able to:
1. State the difference between HIV and AIDS 
2. State how HIV is transmitted and not transmitted 
3. Explain how HIV affects the immune system
Lecture/Discussion
• The definition of HIV and the two types of HIV
• The definition of AIDS
• How HIV is transmitted and how it affects the immune system
Trainer’s Notes
Trainer should be knowledgeable about HIV/AIDS issues in the local context. He or she will explain
that HIV stands for the Human Immunodeficiency Virus. Give a brief overview of HIV, including
HIV-1 and HIV-2. Encourage participants to respond and record the responses on newsprint or
transparency. Explore other resources, such as the NIAID fact sheet “HIV Infection and AIDS: an
Overview”.
Preparation
Include Appendix 3, “Myths and Facts Associated With HIV Transmission.”




By the end of the session, participants will be able to: 
1. Define the window period for HIV
2. Explain how HIV test results are reported
3. Describe the difference between anonymous and confidential testing 
Lecture/Discussion
• The window period for HIV
• The meaning of the HIV test results
• Anonymous and confidential testing
Trainer’s Notes
Trainer should be knowledgeable about HIV/AIDS issues in the local context. He or she will explain
that an HIV test is a test done in two parts. If the first part is positive for HIV antibodies, a Western
Blot or similar test is done to confirm the results. Participants will need to be informed of the
following points.
1. Antibodies to HIV begin being made by the immune system as soon as a person is infected.
2. It is important to remember that if a person is infected with HIV, he or she can transmit the virus
to someone else even if the HIV test does not yet detect any antibodies.
3. Because of the window period, the best time for the first HIV test is about four weeks after
being exposed to HIV.
4. If the first HIV test does not detect antibodies, the person at risk needs to be tested again three
months after the risk for HIV infection happened. After three months, virtually everybody who is
infected with HIV will have enough antibodies to show up on the HIV test and HIV will show up
on the confirming Western Blot. At this time, if the test is negative, the person does not have
HIV infection, but should continue to avoid risky behavior to prevent getting infected in the
future.
Preparation:




By the end of the session, the participant will be able to:
1. Explain what a value is
2. State influences that shape values
3. Explain how values can change
Group Discussion
• Definition of “values”
• Influences that form values
• How a person’s values can change
Trainer’s notes
Trainer should be experienced in group facilitation. Explain that participants in this training will
have different values. Explain that values are not right or wrong, that they are important part of
being human. Ask the group “what is a value?” Record all the participants’ answers on
transparency or newsprint. Encourage participants to write down their responses.
Make sure to touch on the following in the definition:
• Values are strongly held beliefs.
• Values may vary from culture to culture, group to group, etc.
• Values are something a person might argue over.
• A value is something that a person might fight or even die for.
• A value may be so much a part of the person that he or she may take it for granted.
• A value is a long standing assumption that does not change easily.
• A value is something that all the information in the world may not change.
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Discuss with participants that values may change with outside influences.
You may want to include the following:
• The events that occurred on September 11, 2001 
• The birth of a child 
• Death of a close relative or friend 
• Marriage 
• Move to another country
Preparation
Have newsprint/transparencies and markers ready to share the group’s input.
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By the end of the session, the participant will be able to:
1. Describe the goals of the TB program when referring close contacts for HIV VCT.
2. Identify close contacts that should be recommended for VCT.
3. Describe the plan for action for VCT referral for TST positive and TST negative contacts.
4. Explain the links for VCT between DOH and private MD or Community Based Organizations.
5. Discuss required local documentation.
Lecture/Discussion
• Explain the TB program goals for referring close contacts for VCT.
• Explain the criteria for which close contact should be referred.
• Explain the plan of action for referring contacts who have positive TST and negative TST results.
• Discuss the links for VCT between DOH and private MD’s or Community Based Organizations.
• Explain and demonstrate the use of forms for documenting tests, referrals, and actions.
Trainer’s Notes
Trainer should be familiar with local health services. Trainer will explain to the participants the TB
Control program’s goals for referring close contacts for VCT. Identify priority population to whom
the TB Control program will offer HIV counseling, testing, and referral. Explain the plan of action
for referring clients with both positive and negative TSTs for VCT, and when appointments should
be scheduled for VCT. Discuss TB Control program links between DOH and private MD or
Community Based Organization for VCT. Explain to participants what forms are needed, what
information needs to be documented, and who is responsible for follow-up.
Preparation
TB Control program needs to provide materials that will state purpose and goals for the VCT
project and all forms that will be used for the VCT project, and all forms that will be used.
LESSON SIX
BARRIERS IN THE FIELD
Objectives
By the end of the session, the participant will be able to:
1. Identify barriers to discussing VCT for HIV when conducting a TB contact investigation.
2. Identify solutions for barriers.
Lecture/Discussion
• Barriers when conducting contact investigations
• Breaking down those barriers
Trainer’s Notes
Trainer should be experienced in group facilitation and familiar with contact investigation
procedures. He or she should engage participants in discussion about barriers that they encounter
in the field when they are investigating close contacts. Identify barriers and brainstorm solutions. 
You may want to include the following barriers:
• Lack of private space for discussion of HIV
• Presence of spouse, parents, or children
• Cultural values which discourage the discussion of sex 
• Stigma about HIV 
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By the end of the session, the participant will be able to:




Trainer should be experienced in group facilitation. He or she will divide participants into groups of
three. Have one participant play the role of the CI, the second participant will play the close
contact, and the third will be the observer who will give feedback. Have each participant play all
three roles. End the session by discussing participants’ comments.
Preparation
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Missed Opportunities for Prevention of Tuberculosis Among Persons With HIV Infection
–Selected Locations, United States, 1996–1997
Public health contact investigations are conducted to find persons who have been exposed to
patients with active tuberculosis (TB) and to evaluate and treat those contacts for TB infection and
active TB. Persons in close (i.e., prolonged, frequent, or intense) contact with patients with active
TB are at high risk for TB infection. The risk for TB infection is increased greatly if the close contact
is infected with human immunodeficiency virus (HIV) (1,2). Isoniazid (INH) treatment for latent TB
infection (LTBI) reduces the risk for developing active TB by 41%–92% (1). This study examined the
clinic records of TB programs to determine whether these programs used recommended practices
to manage HIV-positive persons exposed to TB (3–8). The study suggests TB programs need to
review their contact investigation policies, procedures, and outcomes to reduce missed
opportunities for preventing active TB among HIV-positive close contacts. 
Study investigators collected data during June 1998–January 1999 site visits. Eleven U.S. urban areas
were selected by the highest number of contacts completing LTBI treatment. After case reports were
linked to personal identifiers, study staff reviewed the clinic records for 6225 close contacts to 1080
sputum–smear–positive TB patients reported to CDC during July 1996–June 1997.
Of the 6225 close contacts, HIV status was unknown for 5415 (87%). Of the 810 close contacts
with known HIV status, 109 (13%) were HIV-infected, of whom 79 (72%) received a chest
radiograph; 14 (13%) had TB symptoms (e.g., cough, night sweats, and weight loss); 90 (83%)
received an initial tuberculin skin test (TST); and nine (8%) did not receive a chest radiograph or an
initial TST. Forty (53%) of 75 TST-negative contacts did not receive follow-up TSTs; 21 (28%)
received neither a follow-up TST nor a chest radiograph. Fourteen (13%) of 109 HIV-positive
contacts were identified as having active TB compared with 120 (2%) of 6116 HIV-negative
contacts or contacts with unknown HIV status. HIV-infected close contacts were less likely to be
TST-positive than HIV-negative contacts or contacts with unknown HIV status (14% and 36%,
respectively).
Among 95 HIV-infected contacts without active TB, 11 (92%) of 12 TST-positive contacts were
placed on LTBI treatment compared with 19 (23%) of 83 TST-negative or TST-unknown contacts. A
median of 50 days passed before starting an HIV-positive contact on LTBI treatment compared
with 33 days for HIV-negative contacts or contacts with unknown HIV status. TB programs
employing public health nurses to conduct investigations placed 11 (92%) of 12 TST-negative or
TST-unknown contacts on LTBI treatment compared with eight (11%) of 71 at programs that
employ TB outreach workers.
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Of the 30 HIV-positive contacts started on LTBI treatment, approximately half (14) completed
treatment. Directly observed treatment (DOT) for LTBI was given to three HIV-positive contacts;
two completed treatment. During the course of LTBI treatment, 10 HIV-infected contacts had
interruptions of >1 month (when treatment was self-administered) or >2 weeks (when placed on
DOT); three of the 10 completed treatment. Of 16 HIV-positive close contacts who did not
complete treatment, six (38%) refused or were unwilling to continue treatment, two (12%) were
lost to follow-up, one (6%) had alcoholism, one (6%) could not tolerate medication, and six
(38%) had undocumented reasons.
Reported by: TB programs in Los Angeles County, San Diego County, San Francisco, and Santa
Clara County, California; Fulton County, Georgia; Chicago, Illinois; Newark, New Jersey; New York,
New York; Shelby County, Tennessee; Houston, Texas; and King County, Washington. Prevention
Effectiveness Section, Research and Evaluation Br, Div of TB Elimination, National Center for HIV,
STD, and TB Prevention, CDC.
Editorial Note:
The study showed that few close contacts were assessed for HIV and that one quarter of those
known to be HIV-infected were not screened completely for TB. Of eligible HIV-positive contacts, a
third started and a sixth completed LTBI treatment. Because HIV positivity alters the approach to
TB screening and the use of LTBI treatment, early knowledge by the health-care provider of a close
contact’s HIV status is essential. Active TB is curable and can be prevented in HIV-positive contacts
when health-care providers know a close contact’s HIV status and follow CDC guidelines for TB
screening and treatment and facilitate adherence to TB treatment.
Health-care providers should assess all close contacts for HIV infection by asking about their
serostatus and offering voluntary HIV counseling and testing when the status is unknown (8). TB
staff should be trained to offer HIV counseling and testing to close contacts or should collaborate
with HIV programs to offer these services. The use of rapid diagnostic tests may facilitate timely
assessment of HIV status. All HIV-positive close contacts should be evaluated for active TB by
medical history, symptom screening, and chest radiograph, and those with an abnormal chest
radiograph or symptoms should receive a sputum examination (5). HIV-positive close contacts
should receive an initial TST regardless of previous TST results (5); those with initial TST-negative
reactions should receive a follow-up TST 10—12 weeks after last exposure to the patient with
active TB (4). As soon as active TB is excluded, LTBI treatment should begin for all HIV-infected
close contacts regardless of age, TST results, or history of previous LTBI treatment (5). Most HIV-
positive close contacts should complete a full course of LTBI treatment (9). Because the
HIV-positive population is less likely to react to TST and more likely to have atypical chest
radiographs, health-care providers need to be diligent in diagnosing TB infection and active TB.
Two treatment regimens, 9 months of INH (to be taken with pyridoxine to prevent peripheral
neuropathy) or 2 months of daily rifampin (or rifabutin for those taking protease inhibitors or
certain nonnucleoside reverse transcriptase inhibitors) and pyrazinamide, are preferred for the
treatment of HIV-positive persons with LTBI (10). The use of 2-month LTBI regimens for HIV-
infected adults may facilitate treatment implementation and increase completion rates (10).
However, INH is the only recommended regimen for children and pregnant women (5). The
findings in this study are subject to at least three limitations. First, because the study relied on
existing clinic records, documentation of HIV status often was incomplete or nonexistent. Laws
restricting the recording of HIV status in databases may have affected such documentation.
Second, the timing of health-care provider knowledge of HIV status and chest radiograph results
was unknown because these dates were not collected and often were not recorded. Third, this
study was designed to represent urban TB programs not rural programs or programs not using
LTBI treatment.
These findings indicate a need for better incorporation of HIV assessment into contact
investigation procedures and improved coordination between local TB and HIV programs to
facilitate voluntary HIV counseling, testing, and follow-up for HIV-infected close contacts. Health-
care providers and HIV-infected persons should be aware of optimal management of close
contacts and of the benefits of prompt and well-supervised LTBI treatment to prevent active TB.
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APPENDIX 2
SAMPLE LETTER FROM THE DEPARTMENT OF HEALTH
Bureau of Tuberculosis Control
Dear TB Control Staff
HIV is the most powerful known risk factor for reactivation of LTBI to active disease. Persons
infected with both TB and HIV are up to 800 times more likely to develop TB disease. Until recently,
the efforts to control TB among HIV-infected people have focused mainly on active TB patients.
While voluntary HIV testing of TB contacts has been recommended by CDC since 1996, a recent
CDC study entitled “ Missed opportunities for prevention of tuberculosis among persons with HIV
infection selected locations, United States, 1996-1997” (MMWR 2000; 49 (30): 685.
http://www.cdc.gov/mmwr/preview/mmwrhtm/mm4915a1.htm) found low knowledge by TB
providers of HIV status of close contacts to infectious TB patients. In the study, HIV status was
documented for only 13% of 6,225 close contacts to 1,080 infectious TB patients.
There is no doubt that some contacts may, as a result of not knowing their HIV status, have
delayed diagnoses of active TB, resulting in missed opportunities for TB treatment and prevention
of TB transmission. In addition, HIV infected contacts in whom TB disease has been excluded may
miss the opportunity to treated for LTBI prophylatically to prevent the development of active TB.
Moreover, the low reporting of HIV-status prevents our TB control program from knowing the
extent of HIV-infection among person at risk for tuberculosis.
To expand our efforts to control TB among HIV-infected persons who are close contacts to
infectious TB patients, the Bureau of Tuberculosis Control recommends that HIV counseling,
testing and referral be offered to all persons who are close contacts to a pulmonary or
laryngeal TB case and who do not know their HIV status, regardless of the TST result.
DOH staff will assist in identifying individuals who are exposed. The DOH Chest Clinic,
Community-Based Organization, Managed Care Organization,  ___, or ___ will provide HIV
counseling and testing, and make the appropriate referral for counseling, testing, and referral
services. Please see attached protocol. The Department appreciates your assistance and
cooperation in our efforts to eliminate TB.
Sincerely,
Jane Doe, MD
Director, Bureau of Tuberculosis Control 
APPENDIX 3
Trainer’s notes:
This is an exercise that can be used with participants to explore myths and facts associated with HIV
transmission. Hand out work sheets and give the participants about 3 minutes to check items that do
not transmit HIV. Then discuss each item as a group to see which do and do not transmit HIV.
Myths and Facts Associated With HIV Transmission














Myths and Facts Associated With HIV Transmission
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APPENDIX 4 
Values Clarification Questionnaire 
Write the number (5–1) that most closely shows how you feel in the blank before each question.
Strongly Agree Doesn’t Matter Strongly Disagree
5 4 3 2 1
1. _________ I would judge someone who injected drugs and kept this a secret from his or her
sexual partner a negative person.
2. _________ I think same sex relationships are acceptable.
3. _________ Schools should be more active in sex education for students.
4. _________ Using a condom is a sin. 
5. _________ It is natural for partners to talk about sex before they have it.
6. _________ Substance users deserve compassion. 
7. _________ I would be embarrassed to show someone of the opposite sex how to use a
condom.
8. _________ It is OK for unmarried adults to have sex. 
9. _________ Everyone should know their HIV status.
10. _________ Anal sex is unnatural.
11. _________ HIV infected women should not have babies.
12. _________ I think we should teach drug users to clean their works. 
APPENDIX 5
Sample Script for Contact Investigator
Note: To be used with close contacts in the field
I am here to talk to you about tuberculosis because you have been in contact with someone who
is sick with tuberculosis.
What is TB?
Tuberculosis is a disease that can seriously damage the lungs and other organs in the body.
However, TB can be prevented with treatment. It also can be cured. 
How is TB spread?
TB is spread through the air from one person to another. The germs are put into the air when a
person with tuberculosis disease of the lungs or throat coughs or sneezes. People nearby may
breathe in the bacteria and become infected. However, not everyone infected with TB bacteria
becomes sick. Tuberculosis is preventable and curable. 
Tuberculin test
For this reason, the Health Department recommends that you have a tuberculin test to determine
whether you have been infected. If you are infected you can receive confidential treatment, free of
charge at our clinic. The tuberculin test is given using a small needle to inject material into the
upper layers of the skin on the forearm. The result of the test is seen 2 to 3 days later by
examining the arm.
Offer the TST (Offer and implant TST first, then provide HIV information.)
Other conditions that affect the result of the test
There are some medical conditions that weaken the body’s immune systems, which can affect the
result of the test. These conditions include: HIV, diabetes, kidney failure, and others. For example,
if a person has both TB and HIV infection, they are 30 to 100 times more likely to get TB disease.
And, the TB will speed up the HIV infection. Here is a brochure that has more information about
this.
What should I do?
The Health Department recommends that all persons who are close contacts to a TB case and who
do not know their HIV status speak with one of the counselors in our clinic to determine whether
you would benefit from testing for other conditions such as HIV.
May I make appointment for you to see a counselor?
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APPENDIX 6
Addressing HIV/AIDS Issues in TB Contact Investigation
Pre & Post Test Answer Key
1. Human Immunodeficiency Virus
2. Acquired Immunodeficiency Syndrome. It is an advanced stage of HIV infection.
3. The time between initial HIV infection and the development if AIDS.





















Muhammad and his family are from Africa, and practice the Muslim faith. The family is living in a
one-bedroom apartment in the city. The family consists of three children ages 5, 8, and 15. The
family has been exposed to TB, and a Contact Investigator has set up an appointment to screen
the family.
Objective: CI needs to discuss HIV status with a Muslim family.
Conflict: The family is fearful of discussing such issues with strangers and health care worker.
Scenario 2
Sung Li is a 68-year-old Japanese born grandmother who has been living in the city for 30 years.
Sung Li has recently lost her husband to illness. Sung Li has been contacted by a health care
worker who explained that she may have been exposed to TB and that she needs to be screened.
Objective: CI needs to discuss HIV status with an elderly Asian woman.
Conflict: Sung Li does not see the need to talk about her HIV status.
Scenario 3
James is a 22-year-old African American college graduate who recently moved to the city from
college in the South. A Contact Investigator has contacted James and explained that he might
have been exposed to TB and needs to be screened.
Objective: CI needs to discuss HIV status.
Conflict: James feels that the CI should only be asking him questions that pertain to TB, and
should not be discussing his HIV status.
Scenario 4
Maria, an 18-year-old Latina, lives with her mother and younger brother in a two-bedroom
apartment. Maria was exposed to TB at her part time job. A Contact Investigator has come to
Maria’s house to screen her.
Objective: CI has to discuss Maria HIV status.
Conflict: Maria’s mother wants to know why the CI is asking her daughter questions about her
HIV status.
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Scenario 5
Juan is an undocumented Mexican construction worker who shares a two-bedroom apartment
with five other Mexican men. Juan speaks very little English and works long hours. After many
tries, the Contact Investigator is able to contact Juan. He informs him that he may have been
exposed to TB and needs to be screened.
Objective: CI has to discuss HIV status with Juan in the crowded apartment.
Conflict: Juan is afraid to talk to a representative of a public health department and is fearful that
if he has TB or HIV, he will be deported.
Scenario 6
John is a young white professional who has been contacted by a CI, who explained that he might
have been exposed to TB.
Objective: CI must discuss HIV status.
Conflict: John is giving CI a hard time. He refuses to cooperate, he will not reveal his HIV status,
he wants information on who may have exposed him to TB, and he demands to know the
relevancy of his HIV status.
REFERENCES AND OTHER RESOURCES
The best source of information about TB and HIV in your program area is your local heath
department. Organizations providing advocacy and/or services for people living with HIV/AIDS may
also have useful information.
A good place to start when looking for additional information about HIV and Tuberculosis is the
CDC’s National Center for HIV, STD, and TB Prevention: Division of Tuberculosis Prevention. It can
be reached at http://www.cdc.gov/nchstp/tb/default.htm.
The CDC have many free publications. Two of particular interest to TB Contact Investigators are 
1. “Tuberculosis: The Connection Between TB and HIV”. This is a pamphlet designed for client use.
2. “TB and HIV Coinfection: What Can HIV/AIDS Service Organizations do to help?” This pamphlet
is appropriate for CIs.
General Information about HIV is available from CDC’s National Center for HIV, STD, and TB
Prevention: Division of HIV/AIDS Prevention
http://www.cdc.gov/hiv/dhap.htm
For general information about Tuberculosis, see 
“Core Curriculum On Tuberculosis: What the Clinician Should Know”Fourth Edition, 2000.
Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention,
Division of Tuberculosis Elimination
For information about HIV counseling, testing and referral, see 
“Revised Guidelines for HIV Counseling, Testing, and Referral and Revised Recommendations for
HIV Screening of Pregnant Women”
MMWR 2001, Vol. 50, No. RR-19.
For information about TB in HIV-infected patients, see
“Prevention and Treatment of Tuberculosis Among Patients Infected with Human
Immunodeficiency Virus: Principles of Therapy and Revised Recommendations”
MMWR 1998, Vol. 47, No. RR-20.
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Other useful resources are listed below.




National HIV Testing Resources (A service of the CDC)
www.hivtest.org
“Identifying Missed Opportunities for Preventing TB—Resource Manual”
NJM National TB Center
“Performance Guidelines for Contact Investigation: TB Interview—Resource Manual”
NJM National TB Center
“TB Interview for Contact Investigation: Practical Resource for Health Care Worker—Resource
Manual”
NJM National TB Center
Culture & Nursing Care: A Pocket Guide
School of Nursing 
University of California, San Francisco
http://nurseweb.ucsf.edu/www/book4.htm
Reichler MR Bur S, Reves R, Mangura B, Thompson V, Ford J, Castro KG. Results of testing for
human immunodeficiency virus infection among recent contacts of infectious tuberculosis cases in
the United States.
Int J Tuberc Lung Dis 2003 Dec;7 (12 Suppl 3) : S471-8.
Self-Study Modules on Tuberculosis 1-9
Centers for Disease Control and Prevention
Tuberculosis Education and Training Resource Guide
Centers for Disease Control and Prevention
NOTES
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Charles P. Felton National Tuberculosis Center
Harlem Hospital Division of Infectious Diseases
506 Lenox Avenue
New York, NY 10037
telephone: 212-939-8254
fax: 212-939-8259
Website: http://www.harlemtbcenter.org
